{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:50:21Z","timestamp":1774439421618,"version":"3.50.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,15]]},"DOI":"10.2146\/ajhp150136","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T15:20:54Z","timestamp":1462375254000},"page":"631-634","source":"Crossref","is-referenced-by-count":10,"title":["Visual hallucinations associated with gabapentin use"],"prefix":"10.1093","volume":"73","author":[{"given":"Katelyn A.","family":"Parsons","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Western New England University College of Pharmacy, Springfield, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Derkits","sequence":"additional","affiliation":[{"name":"Bethlehem, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041102210993700_b1-ajhp631","volume-title":"Neurontin (gabapentin) package insert","year":"2014"},{"key":"key\n\t\t\t\t2019041102210993700_b2-ajhp631","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00018-003-2108-x","article-title":"Cellular and molecular action of the putative GABA-mimetic, gabapentin","volume":"60","author":"Maneuf","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"key\n\t\t\t\t2019041102210993700_b3-ajhp631","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410390114","article-title":"The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy","volume":"39","author":"Petroff","year":"1996","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t2019041102210993700_b4-ajhp631","unstructured":"Food and Drug Administration. Postmarket drug safety evaluation summaries completed from April 2013 through June 2013. www.fda.gov\/drugs\/guidancecomplianceregulatoryinformation\/surveillance\/ucm373752.htm (accessed 2015 May 31)."},{"key":"key\n\t\t\t\t2019041102210993700_b5-ajhp631","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041102210993700_b6-ajhp631","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/070674370204701017","article-title":"Gabapentin-induced paradoxical exacerbation of psychosis in a patient with schizophrenia","volume":"47","author":"Jablonowski","year":"2002","journal-title":"Can J Psychiatry"},{"key":"key\n\t\t\t\t2019041102210993700_b7-ajhp631","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.70.6.813","article-title":"Charles Bonnet\u2019s syndrome: complete remission of complex visual hallucinations treated by gabapentin","volume":"70","author":"Paulig","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t2019041102210993700_b8-ajhp631","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/jnp.2008.20.3.364","article-title":"Successful treatment of hallucinations associated with sensory impairment using gabapentin","volume":"20","author":"Holroyd","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key\n\t\t\t\t2019041102210993700_b9-ajhp631","volume-title":"Lyrica (pregabalin) package insert","year":"2013"},{"key":"key\n\t\t\t\t2019041102210993700_b10-ajhp631","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1590\/S0004-282X2012001200012","article-title":"Delirium, psychosis, and visual hallucinations induced by pregabalin","volume":"70","author":"Pedroso","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"key\n\t\t\t\t2019041102210993700_b11-ajhp631","volume-title":"Ativan (lorazepam) package insert","year":"2007"},{"key":"key\n\t\t\t\t2019041102210993700_b12-ajhp631","volume-title":"Xanax (alprazolam) package insert","year":"2013"},{"key":"key\n\t\t\t\t2019041102210993700_b13-ajhp631","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/030006059502300108","article-title":"Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland","volume":"23","author":"Ganzoni","year":"1995","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t2019041102210993700_b14-ajhp631","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002826-200001000-00011","article-title":"Central nervous system side effects associated with zolpidem treatment","volume":"23","author":"Toner","year":"2000","journal-title":"Clin Neuropharmacol"},{"issue":"suppl 1","key":"key\n\t\t\t\t2019041102210993700_b15-ajhp631","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","article-title":"The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents","volume":"18","author":"Sanger","year":"2004","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t2019041102210993700_b16-ajhp631","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function","volume":"16","author":"Froissart","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/10\/631\/28334287\/ajhp0631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T04:56:38Z","timestamp":1567832198000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/10\/631\/5101524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,15]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,5,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150136","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,5,15]]},"published":{"date-parts":[[2016,5,15]]}}}